Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

15 Nov 2010 07:00

RNS Number : 1376W
Persimmon PLC
15 November 2010
 

 

 

INTERIM MANAGEMENT STATEMENT

 

MONDAY 15 NOVEMBER 2010

 

 

 

Persimmon plc today releases its Interim Management Statement which covers the period from 1 July 2010 to 15 November 2010 and confirms current trading in line with expectations.

 

Since 1 July 2010, sales volumes have remained stable with sales prices and margins holding firm. Although weekly sales increased gradually during September, we did not experience the normal autumn increase in visitor levels and reservations. Cancellation rates remain at a low level of c. 19%.

 

As previously stated at the time of our Half Year Results announcement, we anticipate increasing our sales revenues by c. 10% this year. We expect to legally complete c. 9,400 homes for the year ending 31 December 2010 (2009: 8,976), an increase of c. 5%. We have continued to generate good levels of free cash and now expect that total borrowings at the year end will be lower than £80 million, well ahead of previous guidance.

 

Consistent with our stated strategy of focusing on improving margins, we expect to increase underlying operating margin for the full year to c. 8% (2009: 4%).

 

Mortgage availability remains a major obstacle for customers who wish to purchase a home, especially first time buyers who do not have the required large deposits. Further recovery in industry output and sales will be dependent upon an increase in the supply of mortgage products on appropriate terms.

 

However, we are fully sold up for the current year and we are in a strong financial position with over £460 million of sales already reserved beyond 2010 (2009: £500 million). Our new site starts are proceeding as planned with 60 new sites opened so far through the second half with another 15 to come through by the end of November. This will maintain the strength of our sales network at c. 380 active sites into the New Year. The outlook for sales and volumes for the full year of 2011 is as usual dependent upon the forthcoming spring selling season.

 

We have remained selective in our land replacement since the half year and have acquired c. 4,000 new plots on 41 sites so far in the second half, including c. 20% of plots from our strategic landbank. These investments continue to be made at good margins and will offer excellent returns to the business over the medium term. We also continue to improve the quality of our existing landbank in support of the delivery of improving underlying operating margins.

 

In summary, we expect our performance for 2010 to demonstrate the progress we have made in pursuing our strategy of operating margin improvement and growth in operating cash generation. With the strength of our balance sheet and high quality land holdings we will continue to successfully develop our business in these challenging markets.

 

We will give a further update on progress and trading following the year end on Monday 10 January 2011.

 

For further information, please contact:

 

Edward Orlebar

Charlotte McMullen

Marylène Guernier

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

M:Communications

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7920 2369

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUABRRWAAAAA
Date   Source Headline
23rd Jun 201710:05 amRNSHolding(s) in Company
1st Jun 20172:42 pmRNSBlock listing Interim Review
1st Jun 20172:39 pmRNSTotal Voting Rights
31st May 201710:03 amRNSHolding(s) in Company
12th May 20175:30 pmRNSHolding(s) in Company
4th May 20174:19 pmRNSHolding(s) in Company
2nd May 201710:45 amRNSTotal Voting Rights
27th Apr 20174:37 pmRNSAGM Statement
27th Apr 20177:00 amRNSTrading Update
11th Apr 201712:52 pmRNSAdditional Listing
5th Apr 20172:05 pmRNSDirector/PDMR Shareholding
3rd Apr 20174:57 pmRNSTotal Voting Rights
31st Mar 201712:31 pmRNSDirector/PDMR Shareholding
20th Mar 20171:58 pmRNSAnnual Financial Report
8th Mar 20174:03 pmRNSDirector/PDMR Shareholding
8th Mar 201711:49 amRNSDirector/PDMR Shareholding
7th Mar 20174:45 pmRNSDirector/PDMR Shareholding
1st Mar 20173:42 pmRNSDirector/PDMR Shareholding
1st Mar 20171:16 pmRNSTotal Voting Rights
27th Feb 20177:00 amRNSFinal Results
23rd Feb 20171:38 pmRNSDirectorate Change
1st Feb 20173:54 pmRNSTotal Voting Rights
31st Jan 20175:20 pmRNSHolding(s) in Company
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20176:12 pmRNSHolding(s) in Company
3rd Jan 201711:13 amRNSTotal Voting Rights
21st Dec 201610:09 amRNSHolding(s) in Company
15th Dec 201612:36 pmRNSHolding(s) in Company
2nd Dec 20164:14 pmRNSBlock listing Interim Review
1st Dec 201610:33 amRNSHolding(s) in Company
1st Dec 201610:26 amRNSTotal Voting Rights
1st Dec 20167:00 amRNSHolding(s) in Company
29th Nov 201610:35 amRNSHolding(s) in Company
25th Nov 20165:21 pmRNSHolding(s) in Company
22nd Nov 20161:38 pmRNSHolding(s) in Company
21st Nov 20161:32 pmRNSHolding(s) in Company
2nd Nov 20167:00 amRNSTrading Statement
1st Nov 201612:34 pmRNSTotal Voting Rights
19th Sep 201611:10 amRNSChange of date of 2016 Full Year Results
1st Sep 20163:32 pmRNSTotal Voting Rights
23rd Aug 20167:00 amRNSHalf-year results for 6 months ended 30 June 2016
1st Aug 20162:35 pmRNSTotal Voting Rights
11th Jul 20163:33 pmRNSDirector Declaration
5th Jul 20169:58 amRNSDirector Declaration
5th Jul 20167:00 amRNSTrading Update
1st Jul 201610:37 amRNSTotal Voting Rights
29th Jun 20165:58 pmRNSEBT Share Purchase
1st Jun 201611:31 amRNSTotal Voting Rights
1st Jun 201611:05 amRNSBlock listing Interim Review
3rd May 201610:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.